89Zr-DFO-girentuximab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 89Zr-DFO-girentuximab, covering 2025-07-08 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC) [Phase 1]